FAM
Formidable Asset Management’s Arcturus Therapeutics ARCT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $156K | Hold |
14,700
| – | – | 0.03% | 372 |
|
2025
Q1 | $156K | Sell |
14,700
-3,500
| -19% | -$37.1K | 0.03% | 373 |
|
2024
Q4 | $309K | Sell |
18,200
-100
| -0.5% | -$1.7K | 0.05% | 296 |
|
2024
Q3 | $425K | Sell |
18,300
-500
| -3% | -$11.6K | 0.07% | 247 |
|
2024
Q2 | $458K | Buy |
18,800
+900
| +5% | +$21.9K | 0.07% | 245 |
|
2024
Q1 | $604K | Buy |
17,900
+2,350
| +15% | +$79.4K | 0.1% | 211 |
|
2023
Q4 | $490K | Buy |
15,550
+500
| +3% | +$15.8K | 0.1% | 173 |
|
2023
Q3 | $385K | Buy |
15,050
+100
| +0.7% | +$2.56K | 0.09% | 201 |
|
2023
Q2 | $429K | Hold |
14,950
| – | – | 0.09% | 185 |
|
2023
Q1 | $384K | Sell |
14,950
-900
| -6% | -$23.1K | 0.08% | 200 |
|
2022
Q4 | $269K | Buy |
15,850
+200
| +1% | +$3.39K | 0.06% | 241 |
|
2022
Q3 | $261K | Buy |
15,650
+700
| +5% | +$11.7K | 0.06% | 234 |
|
2022
Q2 | $235K | Buy |
14,950
+900
| +6% | +$14.1K | 0.05% | 254 |
|
2022
Q1 | $379K | Buy |
14,050
+1,100
| +8% | +$29.7K | 0.07% | 224 |
|
2021
Q4 | $498K | Sell |
12,950
-300
| -2% | -$11.5K | 0.1% | 188 |
|
2021
Q3 | $633K | Buy |
13,250
+925
| +8% | +$44.2K | 0.12% | 166 |
|
2021
Q2 | $346K | Buy |
12,325
+5,450
| +79% | +$153K | 0.07% | 207 |
|
2021
Q1 | $278K | Buy |
+6,875
| New | +$278K | 0.06% | 223 |
|
2020
Q3 | – | Sell |
-4,866
| Closed | -$263K | – | 267 |
|
2020
Q2 | $263K | Buy |
+4,866
| New | +$263K | 0.08% | 194 |
|
2017
Q4 | – | Sell |
-13,435
| Closed | -$14K | – | 116 |
|
2017
Q3 | $14K | Buy |
+13,435
| New | +$14K | 0.01% | 195 |
|
2017
Q1 | – | Sell |
-13,785
| Closed | -$29K | – | 193 |
|
2016
Q4 | $29K | Sell |
13,785
-2,300
| -14% | -$4.84K | 0.01% | 169 |
|
2016
Q3 | $40K | Buy |
16,085
+1,600
| +11% | +$3.98K | 0.02% | 166 |
|
2016
Q2 | $61K | Buy |
+14,485
| New | +$61K | 0.03% | 157 |
|